Insomnia Treatment Market Expected to Grow at 5.2% CAGR from 2024 to 2034

The global insomnia treatment market (不眠症治療市場) is projected to reach a value of US$ 6,886.1 million by 2024 and is expected to grow at a CAGR of 5.2% from 2024 to 2034, reaching US$ 11,385.5 million in 2034. A key driver of this growth is the increasing awareness and understanding of insomnia among patients and healthcare professionals. Insomnia is a prevalent sleep disorder affecting millions worldwide, driving the demand for effective treatments and creating a diverse market for insomnia treatment products and therapies aimed at enhancing sleep quality and duration.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9613

Market Dynamics

Several factors contribute to the growth of the insomnia treatment market. These include the rising prevalence of insomnia, increasing awareness about the disorder and its consequences, and the growing adoption of sedentary lifestyles leading to sleep disturbances. Additionally, the availability of a wide range of treatment options, including medications, cognitive behavioral therapy, and alternative therapies, further fuels market growth.

On the other hand, factors such as side effects associated with medications, lack of access to healthcare facilities, and the high cost of some treatments can hinder market growth. However, advancements in technology, such as wearable sleep trackers and telemedicine, are expected to create new opportunities in the market.

Market Future Outlook

The insomnia treatment market (불면증 치료 시장) is expected to witness significant growth in the coming years. This growth can be attributed to the increasing prevalence of insomnia, growing geriatric population, and rising awareness about the importance of sleep in maintaining overall health. Moreover, the market is likely to benefit from ongoing research and development activities aimed at introducing innovative treatment options with improved efficacy and fewer side effects.

Market Insights

The insomnia treatment market is segmented based on treatment type, which includes medications, cognitive behavioral therapy, and others. Among these, medications are the most commonly used treatment option, accounting for a significant share of the market. However, cognitive behavioral therapy is gaining traction due to its effectiveness in treating insomnia without the side effects associated with medications.

Geographically, North America dominates the insomnia treatment market, followed by Europe. This can be attributed to the high prevalence of insomnia in these regions, coupled with the presence of well-established healthcare infrastructure. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, driven by factors such as the increasing awareness about sleep disorders and the growing demand for effective treatment options.

Key Players

Paratek Pharmaceuticals, Inc.
Vanda Pharmaceuticals Inc.
Sanofi S.A
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Teva Pharmaceutical Industries Limited
Viatris Inc.
Takeda Pharmaceutical Company Limited
Pfizer Inc.

Competitive Landscape

Key players in the insomnia treatment industry include pharmaceutical companies as well as startups specializing in alternative remedies and supplements like melatonin and valerian root. As the prevalence of insomnia and related conditions continues to rise, competition in the market is expected to increase.

In 2021, HoneyNaps announced its plans to launch a digital therapy business focused on treating insomnia. The platform includes SOMNUM, an AI-based program for diagnosing sleep problems, My SOMNUM, a non-contact sleep analysis and coaching solution, and SOMNUM Medella, a digital treatment for insomnia.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9613

Segmentation of Insomnia Treatment Market (Markt für die Behandlung von Schlaflosigkeit) Research

By Drug Type:

OTC Drugs

Prescription Drugs

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

eCommerce

Drug Stores & Hypermarkets

By Region:

North America

Europe

Latin America

East Asia

South Asia & Oceania

Middle East & Africa

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.